ADAR1 inhibition with 8-azaadenosine treatment significantly attenuated gastric cancer peritoneal tumor metastasis as well as decreased the expression of the CALR oncogene, the Wnt/β-catenin signaling pathway and EMT process in vivo. The gene discussed is ADAR; the disease is gastric cancer.